3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
24
Fallopian Tube Neoplasms
20
Breast Neoplasms
10
Carcinoma, Ovarian Epithelial
8
Sarcoma
6
Neoplasms
4
Neoplasm Metastasis
4
Triple Negative Breast Neoplasms
3
Sarcoma, Kaposi
2
Sarcoma, Ewing
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Multi-centric Castleman's Disease
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Leiomyosarcoma
2
Hodgkin Disease
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
AIDS-related Kaposi sarcoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Vaccinia
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Recurrence
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Interventions
Oxaliplatin
66
pembrolizumab
48
Fluorouracil
44
Capecitabine
39
Nivolumab
33
Leucovorin
32
Paclitaxel
28
Trastuzumab
21
Docetaxel
19
Cisplatin
18
S 1 (combination)
17
Bevacizumab
15
Irinotecan
14
Drug Therapy
14
Ramucirumab
13
tislelizumab
12
Cyclophosphamide
12
fludarabine
10
Carboplatin
10
sintilimab
9
Radiotherapy
9
Magnetic Resonance Spectroscopy
9
trastuzumab deruxtecan
8
atezolizumab
8
Specimen Handling
8
Biopsy
8
durvalumab
7
Surgical Procedures, Operative
7
Gemcitabine
7
zolbetuximab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
liposomal doxorubicin
×
1 year
×
Clear all
No trials found.